Jaakko Lappalainen, MD, PHD
Addiction Psychiatry Physician · Philadelphia, PA
Jaakko Lappalainen, MD, PHD is an addiction psychiatry physician with a practice address in Philadelphia, Pennsylvania, and NPI 1518383587, issued on Mar 13, 2014. Check the license (Pennsylvania MD449638, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Jaakko Lappalainen
- Credential
- MD, PHD
- Primary taxonomy
- Addiction Psychiatry Physician 2084P0802X
- License numbers
- MD449638 PA
038241 CT
Self-reported in NPPES; status is on the state search - Practice location
- 3900 Woodland Ave, Philadelphia, PA 19104
- Phone
- (203) 676-1599
- Enumerated
- Mar 13, 2014
- Record last updated
- Mar 13, 2014 (not updated in 12 years: call before relying on the address or phone)
- Entity
- Type 1 · individual
8 nearest addiction psychiatry physician records → All 29 in Pennsylvania → Look up another NPI →
Also registered at 3900 Woodland Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kate AbramsonClinical Social Worker1326801457
- Erin Abrigo, PH.D.Clinical Psychologist1710380290
- Chinyere Achi, CRNPAdult Health Nurse Practitioner1164533469
- Gunsel Acikgoz, MDDiagnostic Radiology Physician1225062334
- Kate Acker, CRNPNurse Practitioner1922876408
- Tiffany Adeleke, PHARMDPharmacist1194334011
Verify Jaakko Lappalainen in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD449638Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
78% fewer Medicare Part D claims than the average addiction psychiatry physician in 2024
159 Medicare Part D claims for 24 beneficiaries, against an average of 716 among the 421 providers of this specialty who prescribed in Part D. Brand-name drugs were 13% of claims.
Most prescribed
- Trazodone Hcl24 claims
- Hydroxyzine Pamoate17 claims
- Doxepin Hcl11 claims
- Suboxone11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $187.59
5 payments; by number, the most common kind was food and beverage; the largest payer was E.R. Squibb & Sons, L.L.C. The 170 providers of this specialty with any payment received $1,785.85 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Jaakko Lappalainen among 29 addiction psychiatry physician records in Pennsylvania
Jaakko Lappalainen, MD, PHD is one of 29 addiction psychiatry physician records with a practice address in Pennsylvania. 59% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2014, is newer than 83% of them.
- NPI issued2014 · 83% of these records are older, 10% newer
- In a Medicare fileYes · 59% of these records are
- In the CMS Doctors and Clinicians fileNo · 31% of these records are
- Record last updated2014 · 45% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 2084P0802X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Addiction Psychiatry Physician providers in Pennsylvania
There are 29 addiction psychiatry physician records in Pennsylvania.
All 29 in Pennsylvania → Every provider in Philadelphia → Addiction Psychiatry Physician nationwide →
The 8 addiction psychiatry physician records with the nearest ZIP codes
- Peter Garrett, DOPhiladelphia, PA 191041144858218
- Edwin Kim, MDPhiladelphia, PA 191041134549504
- Henry Kranzler, MDPhiladelphia, PA 191041205832201
- Daniel Langleben, MDPhiladelphia, PA 191041578579280
- Laura McNicholas, M.D.Philadelphia, PA 191041639180615
- Elmer Yu, MDPhiladelphia, PA 191041841226545
- David Buch, MDPhiladelphia, PA 191071467526756
- Abigail Kay, MDPhila, PA 191071669498903
Common questions
What is Jaakko Lappalainen, MD, PHD's NPI number?
Jaakko Lappalainen, MD, PHD's National Provider Identifier (NPI) is 1518383587, issued on Mar 13, 2014. An NPI identifies a provider in billing; it is not a license.
Where is Jaakko Lappalainen, MD, PHD located?
The NPPES record lists a practice address at 3900 Woodland Ave, Philadelphia, PA, 19104. Phone: (203) 676-1599. Providers update this record themselves, so call before visiting.
How can I verify Jaakko Lappalainen, MD, PHD's license?
NPPES lists Pennsylvania license number MD449638, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jaakko Lappalainen, MD, PHD prescribe under Medicare Part D?
In 2024, Jaakko Lappalainen, MD, PHD had 159 Medicare Part D claims for 24 beneficiaries; the average among addiction psychiatry physician prescribers was 716. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.